News

An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer ...

ultraspect xpress.cardiac nuclear imaging spect radiation dose

As the global medical isotope shortage continues indefinitely following the plant leak in South Africa, Berks Cardiologists Ltd., a cardiovascular imaging center in central Pennsylvania, is...

radiopharmaceuticals and tracers nuclear molecular imaging FDA lexiscan

The U.S. Food and Drug Administration (FDA) is warning healthcare professionals of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress test agents Lexiscan (...

rsna 2013 radiopharmaceuticals tracers nuclear imaging trial study flurpiridaz

Lantheus Medical Imaging, Inc., a developer, manufacturer and distributor of diagnostic imaging agents,...

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission...

Positron Corporation entered into a multi-year radioisotope supply agreement with iThemba LABS of Cape Town, South Africa. The supply agreement contracts the procurement of raw material, strontium...

PET vs SPECT, flurpiridaz

Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been shown to be superior to single photon emission computed tomography (SPECT). Nevertheless, widespread clinical...

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both...

Radiation exposure has become a major public health concern in both lay and medical publications. In nuclear medicine, the recent introduction of hybrid imaging in the form of SPECT/CT and PET/CT...

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems

Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete...

Cardiolite vials

Lantheus Medical Imaging has entered into a new agreement with Fujifilm RI Pharma (FRI) to license and distribute Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for...

Chalk River Labs

Atomic Energy of Canada Limited (AECL) will commence a 30-day planned shutdown for inspection and maintenance of the National Research Universal (NRU) reactor at Chalk River, Ontario, starting...

Lantheus Medical Imaging Inc. announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m...

FDA Approval GE Healthcare's AdreView Nuclear Imaging SPECT systems

GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent...

LEU TechneLite generator

As the U.S. government works to strengthen its global nuclear security strategy by eliminating potential sources of bomb-grade highly enriched uranium (HEU), it has eyed the production of medical...

Lantheus LEU TechneLite generator Mo-99 Nuclear Imaging Radiopharmeceuticals

Lantheus Medical Imaging Inc. has added a low-enriched uranium (LEU) TechneLite (technetium Tc 99m Generator) generator to the its nuclear imaging product portfolio. Lantheus’ LEU TechneLite...

December 26 , 2012 — Congress last week affirmed its dedication to securing a sustainable, domestic supply of molybdenum-99 (Mo-99) as it passed the American Medical Isotope Production Act of...

Lantheus Medical Imaging Inc. and two medical isotope producers have agreed to work together to help ensure supplies of potentially life-saving nuclear medicine using molybdenum-99 (Mo-99) sourced...

October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc-99m) generators...

September 12, 2012  – Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences Company, and Positron have executed a Letter of Intent pertaining to Positron's supply of...

August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file (DMF) with the U.S. Food and Drug Administration (FDA) for the production...

August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical ...

August 3, 2012 — FluoroPharma Medical Inc. announced that they have received high-quality images in an investigator-sponsored clinical trial in China where patients with coronary artery disease (...

August 2, 2012 — According to new research published in the August issue of the Journal of Nuclear Medicine,...

July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds from the redevelopment commission of the city of Gary, Ind.,...

June 15, 2012 — At the Society of Nuclear Medicine’s (SNM) 59th Annual Meeting in Miami Beach, Fla., June 9-12, Cardinal Health introduced new technology enhancements that make it possible...

June 13, 2012 — Positron Corp. announced completion of its first strontium validation effort in May 2012, when Manhattan Isotope Technology (MIT), a Positron subsidiary, successfully...

Best Cyclotron Systems is unveiling five new cyclotrons for isotope research and production at the Society of Nuclear Medicine (SNM) 2012 Annual Meeting on June 9-12 in Miami Beach, Fla.

May 14, 2012 — Lantheus Medical Imaging Inc. announced new manufacturing and supply agreements with Jubilant HollisterStier LLC (JHS). Under separate agreements, JHS will manufacture Cardiolite...

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical...

April 5, 2012 - SK Capital Partners, a U.S. based private investment firm, and IBA (Ion Beam Applications S.A.) announced that they have closed on their previously announced agreement to create...

March 9, 2012 — Researchers have developed a method to label transplanted cells so they can be tracked by magnetic resonance imaging (MRI). In the future, as cell therapies become a more integral...

March 1, 2012 — Cell>Point announced it entered into a licensing agreement for South Korea, Taiwan, Malaysia, Vietnam and the Philippines with Hyun Imc Co. Ltd., headquartered in Seoul, South...

February 24, 2012 — Positron Corp., through its wholly owned subsidiary, Manhattan Isotope Technology LLC (MIT), announced it had received its first shipment of strontium-82 (Sr-82) from the...

January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear cardiology, announced Jan. 23 that its wholly owned subsidiary, Manhattan Isotope...

January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology LLC (MIT). Positron has acquired all of the assets, business operations and...

January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary...

January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac perfusion radiotracer with a list of actions to bring the product back to market.

October 31, 2011 –Lantheus Medical announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare alliance, for...

October 7, 2011 — U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, M.D., released a blueprint containing immediate steps to drive biomedical innovation, while improving...

August 24, 2011 -- Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems, such as cardiac, cancer or neurology, and/or treat certain conditions such as cancers....

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET) scans. The manufacturer, Bracco...

June 10, 2011 — At the Society of Nuclear Medicine’s 58th Annual Meeting in San Antonio, June 4-8, Cardinal Health previewed The Center for the Advancement of Molecular Imaging (The Center), its new...
June 8, 2011 – Research introduced at the Society of Nuclear Medicine's 58th annual meeting this week may lead to much-needed cardiovascular disease screening for diabetic patients at risk of...
Expanding upon its radiopharmacy platform, GE Healthcare is introducing new tracers to the FASTlab multi-tracer platform, an advanced positron emission tomography (PET) chemistry system on which the...
May 20, 2011 -- Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET Infusion System, which features a new design that is 38 percent smaller, power-...
May 18, 2011, – Lantheus Medical Imaging Inc. announced data from a Phase 2 clinical trial that demonstrated positron emission tomography (PET) myocardial perfusion imaging with flurpiridaz F 18...

Much of nuclear imaging depends on a steady supply of an isotope called molybdenum-99 (Mo-99). A byproduct of nuclear fission, Mo-99 is used to produce another radioactive substance, technetium-...

March 11, 2011 – U.S. Food and Drug Administration (FDA) and Lantheus Medical Imaging Inc. today reached agreement on a phase 3 clinical trial design to assess myocardial perfusion using...

March 10, 2011 – The U.S. Food and Drug Administration (FDA) has granted an abbreviated new drug application (ANDA) for a fludeoxyglucose (FDG) F18 injection. Siemens PETNet Solutions is the first...

February 8, 2011 — The only direct National Institute of Standards and Technology (NIST) traceable dose calibrator source for Ga-68 and F-18 is now available in a 1 mCi (37 MBq) sealed source....

February 10, 2011 – A new bill introduced to the U.S. Senate aims to promote sustainable, domestic production of the medical isotope molybdenum-99 (Mo-99). The bill, also known as the American...

December 16, 2010 – Bracco Imaging demonstrated how its customized evidence-based diagnostic imaging solutions are meeting the demands of an evolving radiology market at the Radiological Society...

December 10, 2010 – The first commercial production of generators using molybdenum-99 (Mo-99) produced with low-enriched uranium (LEU) targets in the United States is underway. The Lantheus...

July 28, 2010 – The Council on Radionuclides and Radiopharmaceuticals (CORAR) applauded a recent decision by a Medicare administrative to correct coding, coverage and payment policies for...

July 9, 2010 – Lantheus Medical Imaging Inc. announced this week that it has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope...

July 8, 2010 – The Canadian Nuclear Safety Commission (CNSC) announced this week it has authorized the reactivation of the National Research Universal (NRU) reactor in Chalk River, Ontario, Canada...

June 14, 2010 – A radio tracer is quickly gaining popularity among cardiologists in the United States.

June 8, 2010 - Since August of 2009, Lantheus Medical Imaging has been exploring options to obtain additional molybdenum (Mo-99), which is used to make technetium-99m, an radioisotope used in...

June 8, 2010 – A recent study found a potential new molecular imaging agent combined with post-scan image processing technology could result in crisper pictures of the heart. The results were...

May 20, 2010 – A new partnership enables data communication between Medrad's Intego positron emission tomography (PET) infusion system and Pinestar Technology's Nuclear Medicine Information System...

May 19, 2010 – A new study shows a single photon emission computed tomography (SPECT) imaging agent can identified symptomatic heart failure patients most likely to experience cardiac events.

April 2, 2010 – The FDA, Society of Nuclear Medicine (SNM) and the Radiological Society of North America (RSNA) are hosting a joint two–topic workshop, April 13–14, at the Natcher Conference...

March 16, 2010 – Preliminary results from the single-center study suggest that compared to SPECT myocardial perfusion imaging (MPI), flurpiridaz F18 PET MPI has a higher diagnostic specificity for...

March 9, 2010 – As an alternative to the technetium (Tc-99M) isotope used in many nuclear imaging studies, UltraSPECT is advocating the use of thallium isotope (TI-201) imaging as an alternative...

February 17, 2010 — An agreement has been reached to further augment and diversify a manufacturer's supply of molybdenum 99 (Mo 99) to produce the medical isotope technetium 99m (Tc 99m).

January 26, 2010 – The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) selected GE Hitachi Nuclear Energy (GEH) to help develop a U.S. supply of a radioisotope used in...

January 25, 2010 - Heart failure is a serious medical condition, in which the heart muscle progressively loses its ability to pump blood, that affects more than five million people in the United...

December 18, 2009 - The U.S. radiopharmacy network currently owned by Covidien is being sold to Triad Isotopes in a deal announced today.

Covidien said it decided to divest its network of...

December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam technology as a superior approach to accelerator-based isotope production.

The...

November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the reimbursement for positron emission tomography (PET) cardiac procedures in 2010.

November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo will be released at the American...

November 6, 2009 - As the American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for approval, legislation that would create a stable and reliable supply of medical isotopes...

November 4, 2009 - The Centers for Medicare and Medicaid Services (CMS) released the review copy of the 2010 Hospital Outpatient Prospective Payment System (HOPPS) final rule on Oct. 30, 2009....

October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized medicine, in which therapy is designed for the individual patient, according to a report...